Age and sex distribution of the prevalence of Barrett's esophagus found in a primary referral endoscopy center

American Journal of Gastroenterology

Volumn 100, Issue 3, 2005, Pages 568-576

  Van Blankenstein, Mark ^a   Looman, Caspar W N ^b   Johnston, Belinda J ^b   Caygill, Christine P J ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGE DISTRIBUTION; AGED; ARTICLE; BARRETT ESOPHAGUS; DEMOGRAPHY; ENDOSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX RATIO;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; ENDOSCOPY; ESOPHAGUS; FEMALE; HUMANS; MALE; METAPLASIA; MIDDLE AGED; MUCOUS MEMBRANE; OUTPATIENT CLINICS, HOSPITAL; PREVALENCE; REFERRAL AND CONSULTATION; SEX FACTORS;

EID: 16844367661     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2005.40187.x     Document Type: Article

References (49)

1. Barrett NR. Chronic peptic ulcer of the oesophagus and "oesophagitis". Br J Surg 1950;38:174-82.
2. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-9.
3. Sabel MS, Pastore K, Toon H, et al. Adenocarcinoma of the esophagus with and without Barrett mucosa. Arch Surg 2000;135:831-835; Discussion 836.
4. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-53.
5. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002;97:1888-95.
6. Dulai GS, Guha S, Kahn KL, et al. Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: A systematic review. Gastroenterology 2002;122:26-33.
7. Cameron AJ, Zinsmeister AR, Ballard DJ, et al. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99:918-22.
8. Menke-Pluymers MB, Hop WC, Dees J, et al. Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group. Cancer 1993;72:1155-8.
9. Williamson WA, Ellis FH Jr., Gibb SP, et al. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991;151:2212-6.
10. Johnson DA, Winters C, Spurling TJ, et al. Esophageal acid sensitivity in Barrett's esophagus. J Clin Gastroenterol 1987;9:23-7.
11. Stein HJ, Hoeft S, DeMeester TR. Functional foregut abnormalities in Barrett's esophagus. J Thorac Cardiovasc Surg 1993;105:107-11.
12. Trimble KC, Pryde A, Heading RC. Lowered oesophageal sensory thresholds in patients with symptomatic but not excess gastro-oesophageal reflux: Evidence for a spectrum of visceral sensitivity in GORD. Gut 1995;37:7-12.
13. Pass R, Yalam JM, Camargo L, et al. Increased esophageal chemoreceptor sensitivity to acid in patients after successful reversal of Barrett's esophagus. Dig Dis Sci 1997;42: 1853-8.
14. Loffeld RJ. Young patients with Barrett's oesophagus experience less reflux complaints. Digestion 2001;64:151-4.
15. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002;123:461-7.
16. Rex DK, Cummings OW, Shaw M, et al. Screening for Barrett's esophagus in colonoscopy patients with and without heartburn. Gastroenterology 2003;125:1670-7.
17. GOSPE. Barrett's esophagus: Epidemiological and clinical results of a multicentric survey. Gruppo Operativo per lo Studio delle Precancerosi dell'Esofago (GOSPE). Int J Cancer 1991;48:364-8.
18. van Blankenstein M, Looman C, Hop WCJ, et al. What causes the declining incidence of adenocarcinoma in Barrett's oesophagus (ACBO) in the elderly (abstract). Eur J Gastroenterol Hepatol 2002;14:A82.
19. Cameron AJ, Lomboy CT. Barrett's esophagus: Age, prevalence, and extent of columnar epithelium. Gastroenterology 1992;103:1241-5.
20. Caygill CP, Reed PI, Johnston BJ, et al. A single centre's 20 years' experience of columnar-lined (Barrett's) oesophagus diagnosis. Eur J Gastroenterol Hepatol 1999;11: 1355-8.
21. Anonymous. Census Data, 1991-2001, Slough, Newbury, Reading, Wokingham, Windsor and Maidenhead Sbugh Borough Council: 2003.
22. Qualman SJ, Murray RD, McClung HJ, et al. Intestinal metaplasia is age related in Barrett's esophagus. Arch Pathol Lab Med 1990;114:1236-40.
23. Winters C Jr., Spurling TJ, Chobanian SJ, et al. Barrett's esophagus: A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology 1987;92:118-24.
24. Mann NS, Tsai MF, Nair PK. Barrett's esophagus in patients with symptomatic reflux esophagitis. Am J Gastroenterol 1989;84:1494-6.
25. Harle IA, Finley RJ, Belsheim M, et al. Management of adenocarcinoma in a columnarlined esophagus. Ann Thorac Surg 1985;40:330-6.
26. Sanfey H, Hamilton SR, Smith RR, et al. Carcinoma arising in Barrett's esophagus. Surg Gynecol Obstet 1985;161:570-4.
27. Cameron AJ. Epidemiologic studies and the development of Barrett's esophagus. Endoscopy 1993;25:635-6.
28. Eckardt VF, Kanzler G, Bernhard G. Life expectancy and cancer risk in patients with Barrett's esophagus: A prospective controlled investigation. Am J Med 2001;111:33-7.
29. Anderson LA, Murray LJ, Murphy SJ, et al. Mortality in Barrett's oesophagus: Results from a population based study. Gut 2003;52:1081-4.
30. Conio M, Cameron AJ, Romero Y, et al. Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota. Gut 2001;48:304-9.
31. Kubo A, Corley DA. Marked regional variation in adenocarcinomas of the esophagus and the gastric cardia in the United States. Cancer 2002;95:2096-102.
32. Caygill CP, Watson A, Reed PI, et al. Characteristics and regional variations of patients with Barrett's oesophagus in the UK. Eur J Gastroenterol Hepatol 2003;15:1217-22.
33. Bytzer P, Christensen PB, Damkier P, et al. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Am J Gastroenterol 1999;94:86-91.
34. El-Serag HB, Mason AC, Petersen N, et al. Epidemiological differences between adenocarcinoma of the oesophagus and adenocarcinoma of the gastric cardia in the USA. Gut 2002;50:368-72.
35. Loof L, Gotell P, Elfberg B. The incidence of reflux oesophagitis. A study of endoscopy reports from a defined catchment area in Sweden. Scand J Gastroenterol 1993;28:113-8.
36. El-Serag HB, Johanson JF. Risk factors for the severity of erosive esophagitis in Helicobacter pylori-negative patients with gastroesophageal reflux disease. Scand J Gastroenterol 2002;37:899-904.
37. Sonnenberg A, Steinkamp U, Weise A, et al. Salivary secretion in reflux esophagitis. Gastroenterology 1982;83:889-95.
38. Sarosiek J, Hetzel DP, Yu Z, et al. Evidence on secretion of epidermal growth factor by the esophageal mucosa in humans. Am J Gastroenterol 1993;88:1081-7.
39. Sarosiek J, McCallum RW. Do salivary organic components play a protective role in health and disease of the esophageal mucosa? Digestion 1995;56(Suppl 1):32-7.
40. Rourk RM, Namiot Z, Sarosiek J, et al. Impairment of salivary epidermal growth factor secretory response to esophageal mechanical and chemical stimulation in patients with reflux esophagitis. Am J Gastroenterol 1994;89:237-44.
41. Kongara KR, Soffer EE. Saliva and esophageal protection. Am J Gastroenterol 1999;94:1446-52.
42. Sarosiek J, McCallum RW. Mechanisms of oesophageal mucosal defence. Baillieres Best Pract Res Clin Gastroenterol 2000;14:701-17.
43. Hamilton SR, Smith RR. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987;87:301-12.
44. Reid BJ, Haggitt RC, Rubin CE, et al. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma. Gastroenterology 1987;93:1-11.
45. Haggitt RC. Barrett's esophagus, dysplasia, and adenocarcinoma. Hum Pathol 1994;25:982-93.
46. Csendes A, Smok G, Burdiles P, et al. Prevalence of intestinal metaplasia according to the length of the specialized columnar epithelium lining the distal esophagus in patients with gastroescphageal reflux. Dis Esophagus 2003;16:24-8.
47. Chih-Long C, Sineix P, Save V, et al. In vitro induction and reversal of premalignant Barrett's oesophagus by manipulation I of retinoic acid pathways. Gastroenterology 2004;126:A-46.
48. Franchimont p, Covas A, Brasseur C, et al. Newly developed Barrett's esophagus after subtotal esophagectomy. Endoscopy 2003;35:850-3.
49. Gatenby PAC, Caygill CPJ, Ramus JR, et al. Metaplasia-dysplasia- adenocarcinoma sequence in columnar-lined oesophagus (CLO) in a large UK series. Gut 2004;53:A35.